Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
25.12
-0.64 (-2.48%)
Aug 14, 2026, 4:00 PM EDT - Market closed

Zymeworks Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
37.13105.9776.376.01412.4826.68
Revenue Growth
-69.78%38.87%0.38%-81.57%1446.03%-31.50%
Gross Profit
-91.58-31.04-60.2-66.98203.64-172.86
Operating Income
-155.56-92.55-121.7-137.42130.28-215.29
Net Income
-149.99-81.13-122.7-118.67124.34-211.84
Earnings Per Share
-2.01-1.08-1.62-1.721.90-4.61
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
322.48270.58324.2456.26492.23252.61
Total Debt
16.0118.2718.5326.7528.1332.36
Net Cash (Debt)
306.47252.32305.67429.51464.1220.25
Net Cash Growth
-2.61%-17.45%-28.83%-7.46%110.71%-47.27%
Net Cash Per Share
4.103.354.036.247.114.22

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-119.34-33.01-110.06-118.32144.11-192.45
Capital Expenditures
-1.21-1.52-1.99-2.47-8.15-12.4
Free Cash Flow
-120.54-34.53-112.05-120.8135.96-204.86
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-246.66%-29.29%-78.89%-88.11%49.37%-
Operating Margin
-418.99%-87.34%-159.50%-180.79%31.58%-806.94%
Pretax Margin
-407.76%-75.26%-152.82%-156.87%32.79%-795.95%
Profit Margin
-404.00%-76.56%-160.80%-156.13%30.14%-794.01%
FCF Margin
-324.68%-32.58%-146.85%-158.92%32.96%-767.82%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----4.07-
Forward PE
11.025.435.435.4310.54-
P/FCF Ratio
----3.72-
PS Ratio
48.0118.6013.229.571.2328.60